New biomarkers in epithelial ovarian cancer: needed or redundant?
A StiekemaC M KorseN K AaronsonW J van DrielG G KenterC A R LokPublished in: European journal of gynaecological oncology (2018)
Evaluating the need for new technologies and diagnostics, including biomarkers, is important to avoid expensive research with min- imal clinical implications. In general, there is a perceived need for a new biomarker, if it can be used to improve the accuracy of diagnosis in patients with a pelvic mass.